Moebius Medical is a clinical- stage biotechnology company which is developing a novel and sustainable pain relief treatment for osteoarthritis.

The company’s lead product for osteoarthritis of the knee, MM-II, leverages the physical properties of proprietary liposomes to lubricate the joint and reduce friction and wear, thus leading to joint pain reduction.